SELLAS Life Sciences (SLS) Total Non-Current Liabilities (2019 - 2022)
Historic Total Non-Current Liabilities for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2022 value amounting to $16.1 million.
- SELLAS Life Sciences' Total Non-Current Liabilities rose 18572.44% to $16.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $16.1 million, marking a year-over-year increase of 18572.44%. This contributed to the annual value of $16.1 million for FY2022, which is 18572.44% up from last year.
- As of Q4 2022, SELLAS Life Sciences' Total Non-Current Liabilities stood at $16.1 million, which was up 18572.44% from $13.2 million recorded in Q3 2022.
- Over the past 5 years, SELLAS Life Sciences' Total Non-Current Liabilities peaked at $17.1 million during Q1 2022, and registered a low of $3.9 million during Q1 2020.
- Over the past 4 years, SELLAS Life Sciences' median Total Non-Current Liabilities value was $6.2 million (recorded in 2019), while the average stood at $8.5 million.
- Per our database at Business Quant, SELLAS Life Sciences' Total Non-Current Liabilities plummeted by 5814.2% in 2021 and then surged by 18572.44% in 2022.
- Quarter analysis of 4 years shows SELLAS Life Sciences' Total Non-Current Liabilities stood at $5.6 million in 2019, then surged by 140.1% to $13.5 million in 2020, then plummeted by 58.14% to $5.6 million in 2021, then skyrocketed by 185.72% to $16.1 million in 2022.
- Its last three reported values are $16.1 million in Q4 2022, $13.2 million for Q3 2022, and $13.0 million during Q2 2022.